Abstract
Objectives
The objectives of this study are to evaluate co-morbidities in patients with craniopharyngioma and to elaborate an interdisciplinary protocol of the follow-up.
Patients and methods
The group comprised 15 children (median age at the diagnosis, 10.1; mean follow-up period, 4 years). All patients had surgical resection of the tumour: gross total in seven, subtotal or partial removal in eight cases. Surgery was followed by radiotherapy in ten cases for tumour residue or progression. Sexual development and auxology were evaluated at diagnosis and during follow-up. Hormones were determined by chemiluminescent immunometric assays. Antidiuretic hormone dysfunction was diagnosed on the grounds of clinical symptoms, water-electrolyte balance, urine specific gravity, and serum osmolality. Metabolic control was monitored by levels of glucose, insulin, lipids, and transaminases; insulin resistance was expressed by homeostatic model assessment (HOMA) index.
Results
At diagnosis, median height standard deviation score (hSDS) was −1.6 (five children being short-statured). Median change hSDS for the whole follow-up was 1.2 (four children decelerating growth). Diabetes insipidus was diagnosed in eight (within 0–1.8 years of the follow-up), hypocorticolism in eight, and hypothyroidism in 12 subjects (within 0–3.75 years for both endocrinopathies). Four patients required sex hormone replacement therapy. At diagnosis, five children were overweight; during follow-up, only four children sustained normal body mass index. Hypertransaminasaemia was found in three, dyslipidaemia in 11, and hyperinsulinaemia in seven patients (with elevated HOMA in four cases).
Conclusions
On the grounds of these observations, the management of craniopharyngioma in our institution includes repeated hormonal and metabolic assays in chosen time intervals. Early detection of co-morbidities and their management involves interdisciplinary team.
Similar content being viewed by others
References
Haupt R, Magnani C, Pavanello M, Caruso S, Dama E, Garre ML (2006) Epidemiological aspects of craniopharyngioma. J Pediatr Endocrinol Metab 19(Suppl 1):289–293
Karavitaki N, Cudlip S, Adams CBT, Wass JA (2006) Craniopharyngiomas. Endocr Rev 27:371–397
DeVile CJ, Grant DB, Hayward RD, Stanhope R (1996) Growth and endocrine sequelae of craniopharyngioma. Arch Dis Child 75:108–114
Halac I, Zimmerman D (2005) Endocrine manifestation of craniopharyngioma. Childs Nerv Syst 21:640–648
Palczewska J, Niedzwiecka Z (2001) Wskazniki rozwoju somatycznego dzieci i młodzieży warszawskiej. Med Wieku Rozw 2(Suppl 1):55–56, 113–114
Argente J (1999) Diagnosis of late puberty. Horm Res 51(Suppl 3):95–100
Delemarre EM, Felius B, van de Waal D (2008) Inducing puberty. Eur J Endocrinol 159(Suppl 1):S9–S15
Cizmecioglu FM, Hatun S, Kalaca S (2008) Metabolic syndrome in obese Turkish children and adolescents: comparison of two diagnostic models. Turk J Pediatr 50:359–365
Gungor N, Saad R, Janosky J, Arslanian S (2004) Validation of surrogate estimates of insulin sensitivity and insulin secretion in children and adolescents. J Pediatr 144:47–55
National Cholesterol Education Program (NCEP) (1992) Highlights of the report of the expert panel on blood cholesterol levels in children and adolescents. Pediatrics 89:495–501
Gleeson HK, Shalet SM (2004) The impact of cancer therapy on the endocrine system in survivors of childhood brain tumours. Endocr Relat Cancer 11:589–602
Lyen KR, Grant DB (1982) Endocrine function, morbidity and mortality after surgery for craniopharyngioma. Arch Dis Child 57:837–841
Muller HL, Bruhnken G, Emser A, Faldum A, Etavard-Gorris N, Gebhardt U, Kolb R, Sorensen N (2005) Longitudinal study on quality of life in 102 survivors of childhood craniopharyngioma. Childs Nerv Syst 21:975–980
Perre-Kahn A, Recassens C, Pinto G, Thalassinos C, Chokron S, Soubervielle JC, Brauner R, Zerah M, Siante Rose C (2005) Social and psycho-intellectual outcome following radical removal of craniopharyngiomas in childhood. Childs Nerv Syst 21:817–824
Muller H (2008) Childhood craniopharyngioma. Horm Res 69:193–202
Scott RM (2005) Craniopharyngioma: a personal (Boston) experience. Childs Nerv Syst 21:773–777
Hayward R (1999) The present and future management of childhood craniopharyngioma. Childs Nerv Syst 15:764–769
Albright AL, Hadjipanayis CG, Lunsford LD, Kondziolka D, Pollack IF, Adelson PD (2005) Individualized treatment of pediatric craniopharyngiomas. Childs Nerv Syst 21:649–654
Caldarelli M, Massimi L, Tamburrini G, Cappa M, Di Rocco C (2005) Long-term results of the surgical treatment of craniopharyngioma: the experience at the Policlinico Gemelli, Catholic University, Rome. Childs Nerv Syst 21:747–757
Karavitaki N, Brufani C, Warner JT, Adams CBT, Richards P, Ansorge O, Shine B, Turner HE, Wass JAH (2005) Craniopharyngioma in children and adults: systematic analysis of 121 cases with long-term follow-up. Clin Endocrinol (Oxf) 62:397–409
Tiulpakov AN, Mazerkina NA, Brook CGD, Hindmarsh PC, Peterkova VA, Gorelyshev SK (1998) Growth in children with craniopharyngioma following surgery. Clin Endocrinol (Oxf) 49:733–738
Pinto G, Bussieres L, Recasens C, Souberbielle JC, Zerah M, Brauner R (2000) Hormonal factors influencing weight and growth pattern in craniopharyngioma. Horm Res 53:163–169
Geffner M, Lundberg M, Koltowska-Haggstrom M, Abs R, Verhelst J, Erfurth EM, Kendall-Taylor P, Price DA, Jonsson P, Bakker B (2004) Changes in height, weight and body mass index in children with craniopharyngioma after three years of growth hormone therapy: analysis of KIGS (Pfizer International Growth Database). J Clin Endocrinol Metab 89:5435–5440
Schoenle EJ, Zapf J, Prader A, Torresani T, Werder EA, Zachmann M (1995) Replacement of growth hormone (GH) in normally growing GH-deficient patients operated for craniopharyngioma. J Clin Endocrinol 80:374–378
Karavitaki N, Warner JT, Marland A, Shine B, Ryan F, Arnold J, Turner HE, Wass JA (2006) GH replacement does not increase the risk of recurrence in patients with craniopharyngioma. Clin Endocrinol (Oxf) 64:556–560
Lustig RH, Post SR, Srivannaboon K, Rose SR, Danish RK, Burghen GA, Xiong X, Wu S, Merchant TE (2003) Risk factors for development of obesity in children surviving brain tumors. J Clin Endocrinol Metab 88:611–616
Muller HL, Emser A, Faldum A, Bruhnken G, Etavard-Goris N, Gebhardt U, Oeverink R, Kolb R, Sorensen N (2004) Longitudinal study on growth and body mass index before and after diagnosis of childhood craniopharyngioma. J Clin Endocrinol Metab 89:3298–3305
DeVile CJ, Grant DB, Hayward RD, Kendall BE, Neville BGR, Stanhope R (1996) Obesity in childhood craniopharyngiomas: relation to post-operative hypothalamic damage shown by magnetic resonance imaging. J Clin Endocrinol Metab 81:2734–2737
Hukin J, Visser J, Sargent M, Goddard K, Fryer C, Steinbok P (2005) Childhood craniopharyngioma: Vancouver experience. Childs Nerv Syst 21:758–765
Lustig RH, Rose SR, Burghen GA, Velasquez-Mieyer P, Broome DC, Smith K, Li H, Hudson MM, Heideman RL, Kun LE (1999) Hypothalamic obesity in children caused by cranial insult: altered glucose and insulin dynamics, and reversal by a somatostatin agonist. J Pediatr 135:162–168
Harz KJ, Muller HL, Waldeck E, Pudel V, Roth C (2003) Obesity in patients with craniopharyngioma: assessment of food intake and movement counts indicating physical activity. J Clin Endocrinol Metab 88:5227–5231
Siviero-Miachon AA, Spinola-Castro AM, Guerra-Junior G (2008) Detection of metabolic syndrome features among childhood cancer survivors: a target to prevent disease. Vasc Health Risk Manag 4:825–836
Bramnert M, Segerlanz M, Laurila E, Daugaard JR, Manhem P, Groop L (2003) Growth hormone replacement therapy induces resistance by activating the glucose-fatty acid cycle. J Clin Endocrinol Metab 88:1455–1463
Srinivasan S, Ogle GD, Garnett SP, Briody JN, Lee JW, Cowell CT (2004) Features of metabolic syndrome after childhood craniopharyngioma. J Clin Endocrinol Metab 89:81–86
Bloomgarden ZT (2003) American Association of Clinical Endocrinologists (AACE) consensus conference on the insulin resistance syndrome: 25–26 August 2002, Washington, DC. Diabetes Care 26(933–939):1297–1303
Yeckel CW, Weiss R, Dziura J, Taksali SE, Dufour S, Burgert TS, Tamborlane WV, Caprio S (2004) Validation of insulin sensitivity indices from oral glucose tolerance test parameters in obese children and adolescents. J Clin Endocrinol Metab 89:1096–1101
Manco M, Bottazo G, DeVito R, Marcellini M, Mingrone G, Nobili V (2008) Nonalcoholic fatty liver disease in children. J Am Coll Nutr 27:667–676
Mason PW, Krawiecki N, Meacham LR (2002) The use of dextroamphetamine to treat obesity and hyperphagia in children treated for craniopharyngioma. Arch Pediatr Adolesc Med 156:887–892
Muller HL, Gebhardt U, Wessel V, Schroder S, Kolb R, Sorensen N, Maroske J, Hanisch E (2007) First experiences with laparoscopic adjustable gastric banding (LAGB) in the treatment of patients with childhood craniopharyngioma and morbid obesity. Klin Padiatr 219:323–325
Sosa IJ, Krieger MD, McComb JG (2005) Craniopharyngioma of childhood: the CHLA experience. Childs Nerv Syst 21:785–789
Smith D, Finucane F, Phillips J, Baylis PH, Finucane J, Tormey W, Thompson CJ (2004) Abnormal regulation of thirst and vasopressin secretion following surgery foir craniopharyngioma. Clin Endocrinol (Oxf) 61:273–279
Cuisset JM, Cuvellier JC, Vallee L, Ryckewaert P, Soto-Ares G, Nuyts JP (1999) Holoprosencephaly with neurogenic hypernatremia. Arch Pediatr 6:43–45
Ghirardello S, Hopper N, Albanese A, Maghnie M (2006) Diabetes insipidus in craniopharyngioma: postoperative management of water and electrolyte disorders. J Pediatr Endocrinol Metab 19(Suppl. 1):413–421
Tomlinson JW, Holden N, Hills RK, Wheatley K, Clayton RN, Bates AS, Sheppard MC, Stewart PM, West Midlands Prospective Hypopituitary Study Group (2001) Association between premature mortality and hypopituitarism. Lancet 357:3897–3904
The authors declare that there are no proprietary, financial, professional, or other personal interests that may inappropriately influence positions presented in the manuscript.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kalina, M.A., Skala-Zamorowska, E., Kalina-Faska, B. et al. Practical approach to childhood craniopharyngioma: a role of an endocrinologist and a general paediatrician. Childs Nerv Syst 25, 1053–1060 (2009). https://doi.org/10.1007/s00381-009-0931-6
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00381-009-0931-6